Liang Liu,Lai-Han Elaine Leung,Xiao-Jun Yao,Run-Ze Li
申请号：
US15406798
公开号：
US09744145B1
申请日:
2017.01.16
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This invention provides a method of treating lung cancer including administering a therapeutically effective amount of a compound of 0089-0022 formula I to a subject in need thereof. The compound activates pyruvate kinase M2 isoform (PKM2) to treat the lung cancer. In one example, the lung cancer is Non-Small Cell Lung Cancer (NSCLC).
